Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 May;23(5):653–657. doi: 10.1128/aac.23.5.653

Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.

H Konishi, M Goto, Y Nakamoto, I Yamamoto, H Yamashina
PMCID: PMC184782  PMID: 6223576

Abstract

The in vitro and in vivo inactivation of tobramycin by carbenicillin, ticarcillin, or piperacillin was investigated by the enzyme immunoassay method in clinically employed dosages. After the addition of an 80-mg dose of tobramycin to 4- to 5-g doses of a penicillin in 100 ml of 0.9% saline or distilled water, the degradation profile of tobramycin appeared to follow a biexponential pattern of decay. Remarkable losses (30 to 40%) of tobramycin combined with carbenicillin or ticarcillin were observed within 1 h, as compared with the later decline. The combination of tobramycin with piperacillin was least inactivating. When the admixture of tobramycin with carbenicillin or piperacillin used in the in vitro study was infused to six volunteers over 1 h, the observed maximum concentrations of tobramycin were on the average 66 and 74% for carbenicillin and piperacillin, respectively, of that observed after tobramycin alone was given. In contrast, the value obtained for tobramycin in combination with piperacillin was close to 90% of the control value. The elimination half-lives of tobramycin combined with the penicillins were slightly shorter than those of tobramycin alone, indicating that the interaction occurs even in patients with normal renal function.

Full text

PDF
653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chanbusarakum P., Murray P. R. Analysis of the interactions between piperacillin, ticarcillin, or carbenicillin and aminoglycoside antibiotics. Antimicrob Agents Chemother. 1978 Sep;14(3):505–506. doi: 10.1128/aac.14.3.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Davies M., Morgan J. R., Anand C. Interactions of carbenicillin and ticarcillin with gentamicin. Antimicrob Agents Chemother. 1975 Apr;7(4):431–434. doi: 10.1128/aac.7.4.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Edwards D. J., Schentag J. J. In vitro interactions between beta-lactam antibiotics and tobramycin. Clin Chem. 1981 Feb;27(2):341–341. [PubMed] [Google Scholar]
  4. Ervin F. R., Bullock W. E., Jr, Nuttall C. E. Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother. 1976 Jun;9(6):1004–1011. doi: 10.1128/aac.9.6.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Farchione L. A. Inactivation of aminoglycosides by penicillins. J Antimicrob Chemother. 1981 Jul;8 (Suppl A):27–36. doi: 10.1093/jac/8.suppl_a.27. [DOI] [PubMed] [Google Scholar]
  6. Goto M., Sugiyama M., Ishizaki T. Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers. Antimicrob Agents Chemother. 1980 Sep;18(3):372–376. doi: 10.1128/aac.18.3.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Henderson J. L., Polk R. E., Kline B. J. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin. Am J Hosp Pharm. 1981 Aug;38(8):1167–1170. [PubMed] [Google Scholar]
  8. Iafrate R. P., Hendeles L., Karnes H. T. Measurement of low tobramycin concentrations by the EMIT assay. Am J Hosp Pharm. 1982 Nov;39(11):1965–1966. [PubMed] [Google Scholar]
  9. Kradjan W. A., Burger R. In vivo inactivation of gentamicin by carbenicillin and ticarcillin. Arch Intern Med. 1980 Dec;140(12):1668–1670. [PubMed] [Google Scholar]
  10. Loo J. C., Riegelman S. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. J Pharm Sci. 1970 Jan;59(1):53–55. doi: 10.1002/jps.2600590107. [DOI] [PubMed] [Google Scholar]
  11. Lumish R. M., Norden C. W. Therapy of neutropenic rats infected with Pseudomonas aeruginosa. J Infect Dis. 1976 May;133(5):538–547. doi: 10.1093/infdis/133.5.538. [DOI] [PubMed] [Google Scholar]
  12. McLaughlin J. E., Reeves D. S. Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet. 1971 Feb 6;1(7693):261–264. doi: 10.1016/s0140-6736(71)91001-4. [DOI] [PubMed] [Google Scholar]
  13. Murillo J., Standiford H. C., Schimpff S. C., Tatem B. A. Gentamicin and ticarcillin serum levels. JAMA. 1979 Jun 1;241(22):2401–2403. [PubMed] [Google Scholar]
  14. O'Bey K. A., Jim L. K., Gee J. P., Johnson R. M. Temperature dependence of the stability of tobramycin mixed with penicillins in human serum. Am J Hosp Pharm. 1982 Jun;39(6):1005–1008. [PubMed] [Google Scholar]
  15. Pickering L. K., Gearhart P. Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob Agents Chemother. 1979 Apr;15(4):592–596. doi: 10.1128/aac.15.4.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pickering L. K., Rutherford I. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. J Pharmacol Exp Ther. 1981 May;217(2):345–349. [PubMed] [Google Scholar]
  17. Pieper J. A., Vidal R. A., Schentag J. J. Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions. Antimicrob Agents Chemother. 1980 Oct;18(4):604–609. doi: 10.1128/aac.18.4.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Péchère J. C., Roy B., Dugal R. Distribution and elimination kinetics of intravenously and intramusculary administered tobramycin in man. Int J Clin Pharmacol Biopharm. 1976 Dec;14(4):313–318. [PubMed] [Google Scholar]
  19. Riff L. J., Jackson G. G. Laboratory and clinical conditions for gentamicin inactivation by carbenicillin. Arch Intern Med. 1972 Dec;130(6):887–891. [PubMed] [Google Scholar]
  20. Saikawa I., Takano S., Yoshida C., Saito E., Yasuda T. [Studies on beta-lactam antibiotics for medicinal purpose. IV. Stability of 6-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid (T-1220) in aqueous solution and body fluid (author's transl)]. Yakugaku Zasshi. 1977 Sep;97(9):995–1001. doi: 10.1248/yakushi1947.97.9_995. [DOI] [PubMed] [Google Scholar]
  21. Wagner J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm. 1976 Oct;4(5):443–467. doi: 10.1007/BF01062831. [DOI] [PubMed] [Google Scholar]
  22. White G. W., Malow J. B., Zimelis V. M., Pahlavanzadeh H., Panwalker A. P., Jackson G. G. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother. 1979 Apr;15(4):540–543. doi: 10.1128/aac.15.4.540. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES